CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- 4 Open-market sale Director sold 5,000 shares at $20.50 ($102,500)
- 4 Open-market sale SVP Corp Admin Center sold 1,520 shares at $20.49 ($31,140)
- 4 Open-market sale SVP Corp Admin Center sold 1,299 shares at $20.26 ($26,315)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market sale Director sold 29,278 shares at $20.39 ($596,949)
- 4 Open-market sale Director sold 5,000 shares at $20.23 ($101,167)
- 4 Open-market sale President and General Counsel sold 16,015 shares at an average $20.41 ($326,855)
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale EVP, Production Center sold 2,173 shares at an average $20.50 ($44,549)
- 4 Open-market sale CFO, SVP & Treasurer sold 38,484 shares at an average $20.74 ($797,972)
- 4 Open-market sale SVP Corp Admin Center sold 17,808 shares at an average $20.97 ($373,421)
- 4 Open-market sale President and General Counsel sold 52,296 shares at an average $20.77 ($1,086,420)
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Open-market sale CFO, SVP & Treasurer sold 2,407 shares at $17.59 ($42,333)
- 4 Open-market sale Director sold 10,000 shares at $17.82 ($178,180)
- 10-Q Report Quarterly Report
Page 32 of 48 · 958 filings